Gilead Earnings

Shares of Gilead Sciences, Inc. (NASDAQ: GILD) were trading lower Wednesday after the company's third quarter results fell short of Wall Street's expectations. Following the earnings report, Brian Abrahams of Jefferies lowered the price target to $91 from $95. The analyst noted his Buy...